Matthijs Koorevaar

Company: Johnson & Johnson

Job title: Director, Quality Control, Advanced Therapies Platform

Seminars:

Panel Discussion: Unlocking Tomorrow’s Potential – Advancing Cell Therapy Analytical Development into the Future 3:00 pm

Expectations for the future of cell therapy analytical development include the integration of advanced technologies like high-throughput screening, single-cell analysis, and AI/ML to enhance assay sensitivity, specificity, and biomarker discovery Standardisation and quality control measures to ensure reproducibility and comparability across different laboratories and manufacturing sites, facilitating regulatory approval and commercialisation The development of real-time monitoring techniques and point-of-care testing…Read more

day: Conference Day Two

The Transformative Power of Automation in Analytical Development Through Empowering Streamlined Regulatory Compliance 9:30 am

Explore how automation streamlines sample handling, assay execution, and data analysis in cell therapy analytical development, reducing manual labour and improving efficiency Discuss the role of automation in improving the accuracy and reproducibility of analytical results by minimising human error and variability, leading to more reliable data generation Highlight how automated systems ensure adherence to regulatory requirements by performing standardised…Read more

day: Conference Day Two